BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

November to December 2006

Unique Medical Career Site Offers More Than Just A Simple Job Search

Challenges and Opportunities in the Global Protein Therapeutics Market

Biotech industry publishes new policy agenda for Europe – foreword by Finnish Presidency

University of Cambridge uses G:BOX Chemi HR16 - To Help Rapidly Analyse Polysaccharides from Genetically Modified Plants

Phosphagenics (AIM:PSG) completes Phospha-E pre-clinical trials with Nestlé Nutrition

IntegraGen SA Establishes a US Subsidiary to Commercialize Its Molecular Tests in the USA: Robert Gottlieb Appointed CEO of IntegraGen, Inc.

NEW COMPANY LAUNCHED TO PROMOTE LONDON'S GENETIC RESEARCH CAPABILITY

ABLYNX IDENTIFIES NOVEL NANOBODIES® ACHIEVING FIRST MILESTONE IN PROCTER & GAMBLE COLLABORATION

Unibioscreen announces the launch of its corporate Website

New Montage Explorer Imaging System for Microscopes -Saves Time by Producing One Accurate Image of Large Samples

OXFORD BIOMEDICA'S TROVAX RECEIVES POSITIVE RECOMMENDATION FOR ORPHAN DRUG DESIGNATION IN RENAL CANCER FROM EMEA

Jan van Heek joins PanGenetics' Supervisory Board

CAMBRIDGE ANTIBODY TECHNOLOGY ANNOUNCES SENIOR MANAGEMENT PROMOTIONS

HRA Pharma commences US Phase III trial of second-generation emergency contraceptive

PanGenetics B.V. licenses therapeutic antibody for treatment of pain from Lay Line Genomics S.p.A.

RICERCA BIOSCIENCES, LLC AND THE BICOLL GROUP ENTER SIGNIFICANT COLLABORATION AGREEMENT

OXFORD GENE TECHNOLOGY JOINS CHAVI FUNDED PROJECT TO PROVIDE MICROARRAYS FOR HIV VACCINE RESEARCH

DanioLabs announces postiive clinical results for two lead products

AFFIMED´S FULLY HUMAN ANTI THROMBOSIS ANTIBODY SHOWS IN VIVO EFFICACY WITH REDUCED SIDE EFFECTS

SMEs to Benefit as Seventh Framework Research Programme is Adopted by European Parliament

PanGenetics B.V. licenses therapeutic antibody from Schering-Plough Corporation

With Annual Growth of 31%, Biophotonics Market Zooms to $133 Billion by 2016!

Mass Spectrometry in Biomarker Research to Exceed $745 Million by 2010

Emerging Cancer Vaccine Market Poised to Surpass $8 Billion by 2012

World Respiratory Drug Market Expected to Soar Past $44 Billion by 2010

World Orthopedic Drug Market Expected to Surge Past $44 Billion by 2010

$15 Billion Worldwide Catheter Market Poised for Growth

New Survey from Biocompare - Ranks Syngene Systems Top for Customer Satisfaction

Santaris Pharma awarded Ernst & Young Entrepreneur of the Year 2006

Mining majors join forces to sponsor Virax HIV drug clinical trial in South Africa

SUPELCO SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT WITH MIP TECHNOLOGIES

Thermo Fisher Scientific Introduces the Heraeus Megafuge 11 Benchtop Centrifuge Series

AstraZeneca has announced that it will launch a generic version of its own heart drug Toprol XL.

DR AL KOLB DRIVES CHIP-MAN TECHNOLOGIES EXPANSION INTO USA MARKET

AFFIMED OBTAINS VICTORY IN CHALLENGE TO KEY NAÏVE IGM-BASED ANTIBODY LIBRARIES PATENT

York Pharma (AIM:YRK) Preliminary Results for the Year Ended 30 September 2006

Abcellute Announces Exclusive Agreement with Japanese Biotech Firm, GeneFrontier Corporation

More funds for biotech companies as new State Aid Rules recognize Young Innovative Company Status

PEAKADILLY ANNOUNCES CHANGE OF NAME TO PRONOTA AS IT PROGRESSES STRATEGY TO BECOME WORLD LEADER IN PROTEIN BIOMARKER DISCOVERY

Alpha Biologics Secures Further $3 Million In Latest Funding Round

West Pharmaceutical Services, Inc. Makes Three Key Appointments to Meet Market Demands in Asia-Pacific Region

Virax gets green light for commencement of Phase II US clinical trials of VIR201

SIGMA-ALDRICH ELECTS STEVEN M. PAUL AS DIRECTOR

YORK PHARMA (AIM:YRK) TO ANNOUNCE PRELIMINARY RESULTS 2006 ON FRIDAY 24th NOVEMBER

Biosafety of genetically modified plants: GMO-Safety.eu information portal brings transparency to biosafety research

NAUTILUS BIOTECH AND CREABILIS THERAPEUTICS ACHIEVE TECHNICAL MILESTONE

Astech benefits from pharmaceutical technology investment

SR Pharma plc announces the successful completion of Toxicology Studies for its systemically delivered RNAi product candidate Atu027

Fusion Antibodies announces appointment of new CEO

CERENIS THERAPEUTICS CLOSES €42.1 MILLION FINANCING

OXFORD BIOMEDICA PRESENTS ENCOURAGING PRECLINICAL EFFICACY DATA WITH PROSAVIN IN PARKINSON'S DISEASE

Phosphagenics November 2006 Newsletter

Biotech Industry Welcomes WHO Initiative on Naming of Biologicals including Biosimilar Medicines

RICERCA BIOSCIENCES, LLC APPOINTS R. IAN LENNOX EXECUTIVE CHAIRMAN

Thermo and Research in Immune Tolerance in Transplantation Program Announce Collaborative R&D Agreement

Pushing the boundaries of microfluidics - New Expert Advisory Group is formed to advance Dolomite’s growing application areas

OXFORD BIOMEDICA REPORTS FURTHER ENCOURAGING PHASE II RESULTS WITH TROVAX IN RENAL AND PROSTATE CANCER

SOLEXA ANNOUNCES THIRD QUARTER 2006 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 14

CAMBRIDGE ANTIBODY TECHNOLOGY TO EXPAND OPERATIONS IN CAMBRIDGE, UK, CREATING OVER 200 NEW JOBS

OXFORD BIOMEDICA COMMENCES PHASE III TRIAL OF TROVAX IN RENAL CANCER

Cellexus Biosystems previews its new sterile disposable sampling system for bioreactors at BioProcess 2006 in San Francisco

The 9th International Conference on Biology and Synchrotron Radiation

Xention appoints medical director

Isogenica enters into a research and licence option agreement with UCB

IntegraGen announces €2 million Equity Investment by DSM Venturing, alongside R&D partnership with DSM Personalized Nutrition Group

ABLYNX ENTERS INTO A RESEARCH AND LICENSE AGREEMENT WITH WYETH

ProImmune launches MHC Class II Ultimers for consistent and reliable detection of antigen-specific CD4+ T cells, improving analysis of the immune response

SOLVO Biotechnology and XenoTech LLC Announce North American (US and Canada) Distribution and Service Representation Agreement for Solvo’s Membrane Transporter Assay Products and Services from January 1st 2007.

Cellexus Biosystems appoints first international distributors and announces exhibition schedule for 2007

Pathway Medical closes $25 million Series B funding raising

Sigma-Aldrich Launches First Commercially Available Proteomics Standard

Dow Appoints Pharma Marketing and Education Veteran, Michael S. Altmann, Business Communications/Brand Manager for DowpharmaSM

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006  ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.